The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Health ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

Private sector leaders, philanthropists, and global health experts convened today at the B20 Global Health Breakout, held on the margins of the G20 Leaders' Summit, to spotlight a new wave of ...

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...

Good morning and welcome, everyone, to today's press briefing from the U.S. Department of State's Africa Media Hub. Today, we are discussing the America First Global Health Strategy and the U.S.

Either we get ahead of this crisis or watch a generation of Americans be swept into the devastating grip of disease.

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

In the early 1980s, men and women in the prime of their lives began arriving at Walter Reed Medical Center, wrecked by a disease for which we had no name, ...